Cargando…
Enzyme-Linked Immunosorbent Spot Assay for the Detection of Wilms’ Tumor 1-Specific T Cells Induced by Dendritic Cell Vaccination
Background: Despite recent advances in cancer immunotherapy and the development of various assays for T cell assessment, a lack of universal standards within immune monitoring remains. The objective of this study was to evaluate the enzyme-linked immunosorbent spot (ELISpot) assay in comparison with...
Autores principales: | Higuchi, Yumiko, Koya, Terutsugu, Yuzawa, Miki, Yamaoka, Naoko, Mizuno, Yumiko, Yoshizawa, Kiyoshi, Hirabayashi, Koichi, Kobayashi, Takashi, Sano, Kenji, Shimodaira, Shigetaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344226/ https://www.ncbi.nlm.nih.gov/pubmed/28536414 http://dx.doi.org/10.3390/biomedicines3040304 |
Ejemplares similares
-
Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms’ Tumor 1 in Patients with Advanced Colorectal Cancer
por: Shimodaira, Shigetaka, et al.
Publicado: (2015) -
Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity
por: Koya, Terutsugu, et al.
Publicado: (2017) -
In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination
por: Shimodaira, Shigetaka, et al.
Publicado: (2019) -
Dendritic Cells Pre-Pulsed with Wilms’ Tumor 1 in Optimized Culture for Cancer Vaccination
por: Koya, Terutsugu, et al.
Publicado: (2020) -
Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies
por: Sakamoto, Takuya, et al.
Publicado: (2022)